Searchable abstracts of presentations at key conferences on calcified tissues

ba0007oc11 | (1) | ICCBH2019

Targeting adeno-associated viral vectors to fractures and the skeleton

Lee Lucinda , Peacock Lauren , Lisowski Leszek , Little David , Munns Craig , Schindeler Aaron

Objectives: While local gene therapy for bone applications has shown some success in preclinical models, systemic delivery of transgenes to the skeleton remains a considerable challenge. Viral vectors such as adeno-associated viruses (AAVs) have great potential as vectors for systemic transgene delivery and may be adapted for emerging gene editing technologies. Furthermore, AAV vectors can have high efficiency, low immunogenicity, and selective tropism towards different tissue...

ba0007p40 | (1) | ICCBH2019

Stature and body weight more than age explain functionality level in children with Osteogenesis Imperfecta

Claudio de Castro Luiz , De David Ana , Coelho Giovana , Coccato Livia

Objective: The purpose of this study was to verify the influence of age, body mass and stature on the functionality level of children with Osteogenesis Imperfecta (OI). METHODS: Thirty-eight children (8.21±4.26 years, 19 girls and 52.6% OI type III) were evaluated during their hospitalization for Pamidronate intravenous infusion in the Brazilian Midwest reference hospital for OI treatment (University Hospital of Brasília). Body weight and stature were measured and ca...

ba0007p63 | (1) | ICCBH2019

Bone geometry and microarchitecture deficits in children with Alagille syndrome

Kindler Joseph , Mitchell Ellen , Piccoli David , Grimberg Adda , Leonard Mary , Loomes Kathleen , Zemel Babette

Objectives: Alagille syndrome (ALGS) is an autosomal dominant disorder attributed to mutations in the Notch signaling pathway. Children with ALGS are at increased risk for fragility fracture, but the etiology of this disposition is unknown. Our objective was to characterize bone mass, geometry, and microarchitecture in children with ALGS.Methods: This was a cross-sectional study of 10 children (9 females) ages 8-18 years, with a clinical diagnosis of ALG...

ba0007p173 | (1) | ICCBH2019

Motor and nutritional aspects of individuals with osteogenesis imperfecta assisted in Brazilian midwest region

Castro Luiz Claudio de , Coelho Giovana , Luiz Livia , David Ana Cristina de

Objective: To characterize a group of children with Osteogenesis Imperfecta (OI) followed up at the University Hospital of Brasília (HUB), Brazil.Methods: Data were collected with children and adolescents that were hospitalized in the HUB for intravenous pamidronate infusion treatment. This hospital is an OI reference center of the Midwest region in Brazil. The sample consisted of thirty-eight subjects, of which 50% were female. 52% of the children ...

ba0007p182 | (1) | ICCBH2019

Handgrip strength as functionality and independence indicative in Osteogenesis Imperfecta

Claudio de Castro Luiz , Luiz Livia , Coelho Giovana , Cristina de David Ana

Objectives: This study aimed to correlate handgrip strength and functionality of children with Osteogenesis Imperfecta (OI).Methods: Thirty-eight children and adolescents with different types of OI were single-timed evaluated during their hospitalization for pamidronate intravenous infusion at the University Hospital of Brasília, Brazil. This hospital is the Brazilian Midwest reference for OI treatment through the national health system. These child...

ba0001pp138 | Cancer and bone: basic, translational and clinical | ECTS2013

New chondrosarcoma cell lines and mouse models to study the link between chondrogenesis and chemoresistance

Monderer David , Luseau Alexandrine , Bellec Amelie , David Emmanuelle , Ponsolle Stephanie , Saiagh Soraya , Bercegeay Sylvain , Piloquet Philippe , Denis Marc , Lode Laurence , Redini Francoise , Biger Marine , Heymann Dominique , Heymann Marie-Francoise , Bot Ronan Le , Gouin Francois , Blanchard Frederic

Chondrosarcomas are cartilage-forming, poorly vascularized tumors. With an estimated annual incidence of 1 in 200 000, they represent the second malignant primary bone tumor of adults after osteosarcoma. These tumors are resistant to chemotherapy and radiotherapy, surgical excision remaining the only therapeutic option. However, very few cell lines and animal models are available, and the mechanisms behind their chemoresistance remain largely unknown. Our goal was to establish...

ba0001pp434 | Osteoporosis: treatment | ECTS2013

Bone histology and histomorphometry: effects of 5 years of denosumab in the FREEDOM Extension

Brown Jacques P , Wagman Rachel , Dempster David W , Kendler David , Miller Paul , Bolognese Michael , Valter Ivo , Beck Jensen Jens-Erik , Zerbini Cristiano , Zanchetta Jose R , Daizadeh Nadia , Reid Ian

DMAb increases BMD and reduces bone resorption and risk of vertebral, nonvertebral and hip fractures in women with PMO. Transiliac crest bone biopsies in 47 subjects treated with DMAb for 1–3 years showed reduced bone turnover vs 45 Pbo-treated subjects, which reversed on treatment cessation. Since bone turnover reduction is sustained and fracture incidence low over 6 years’ DMAb treatment, we evaluated DMAb’s effects on tissue-level remodelling in the FREEDOM E...

ba0001pp60 | Bone development/growth and fracture repair | ECTS2013

MEK inhibitors in fracture healing and NF1 pseudarthrosis

Little David , El-Hoss Jad , Kollind Mille , Deo Nikita , McDonald Michelle , Sullivan Kate , Little Chris , Schindeler Aaron

Neurofibromatosis type 1 (NF1) is a genetic disorder with an incidence of 1/3000. Inactivating mutations in the NF1 gene cause Ras-MEK overstimulation, and predisposes NF1 patients to cancer. A new generation of MEK inhibitors (PD0325901 and AZD6244) are under clinical trials in cancer patients, including NF1 patients. Congenital pseudarthrosis of the tibia is a major complication for NF1 patients, and associates with loss-of-heterozygosity of the NF1 gene. The primary aim of ...

ba0001pp181 | Cell biology: osteoblasts and bone formation | ECTS2013

The impairement of bone formation and mineralization in BSP−/− mouse calvaria cell cultures is partly rescued by increasing cell density

Bouet Guenaelle , Bouleftour Wafa , David Marchat , Marie-Therese Linossier , Mireille Thomas , Jane Aubin E , Laurence Vico , Luc Malaval

Bone sialoprotein regulates osteoblast activity and bone formation. In knockout (BSP−/−) mouse bone marrow (BM) stromal cell cultures, the pool of osteoprogenitor (OP) cells (CFU-F number) is not different from wild-type (+/+), nor is their early differentiation (same numbers of alkaline phosphatase positive colonies=CFU-ALP, although these are smaller), while the number of osteoblast, mineralized colonies (CFU-OB) is dramatically reduced. Because ossifi...